Another scientific setback has hit the Dana-Farber Cancer Institute with the retraction of a seventh study, as reported by Becker's Hospital Review, adding to a worrying pattern of alleged image manipulation in published research. The Boston-based institution has been compelled to pull back yet another paper following an internal investigation into multiple irregularities.
Initial scrutiny came about after a Welsh scientist's blog post raised red flags, prompting correction requests for 31 studies in January, alongside the original six retractions, but that has now increased to seven as the institute discovered errors in 37 studies, while Dana-Farber continues to correct the scientific record. Concerns continued as the same blogger identified an additional 30 questionable studies from Dana-Farber authors, extending the potential scale of the academic issue potentially tipping the scientific community into deeper scrutiny, over the integrity of such important research findings.
The institute, while standing firm on its dedication to transparency and responsibility, is also limited by federal regulations when it comes to sharing details, as NBC Boston obtained a statement from Barrett Rollins, MD, PhD, Dana-Farber's research integrity officer, who emphasized the institute's "deep commitment to a culture of accountability and integrity." However, he added, "we are bound by federal regulations ... we cannot share details of internal review processes and will not comment on personnel issues."
Amid the scholarly turmoil, Kenneth Anderson, MD, a name associated with most of the fraudulent studies as a senior author stayed out of the discourse, no comments were offered when his thoughts were solicited, though retractions noted his agreement in pulling his papers—all six having been published focusing on multiple myeloma, the fallout from the scandal cascades through the scientific community, placing other works in potential jeopardy, scrutinizing the myeloma research field with focused intent and raising flags about the veracity of peer-reviewed literature at large.
